COVID-19 Study Assessing the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Adult Outpatients With SARS-CoV-2 Infection
Clinical trial NCT04666441 · COMPLETED
Trial details
- NCT number
- NCT04666441
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-15
- Primary completion
- 2021-03-04
- Enrollment
- 1149
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.